In the phase III trial, it was shown that although the overall decrease in death rate did not reach statistical significance, a notable decrease in mortality was observed specifically among patients who presented with SIC at the beginning of the study.
← all excerpts
Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies.
1
—
—